TO determine if anti-cyclic citrullinated peptide antibody (anti-CCP) positivity is associated With elevated cardiovascular risk in patients with rheumatoid arthritis (RA) and in tients without anv autoimmune disease.
PDFTo evaluate the prevalence of non-adherence to corticosteroid. disease-modifying antirheumatic drug (DMARD) and biologic treatments in patients managed for chronic inflammatory rheumatic disease (CIRD)
PDFHaematological manifestations are frequently seen in systemic lupus erythematosus (SLE). Although mild cytopaenia is common in SLE, rarely are blood dyscrasias the presenting features of the disease.
PDFUnfortunately, the currently avai-lable therapies of this puzzling disorder remains modest. To go any further, we must thetefore focus on its pathophysiopathology. Fibromyalgia syndrome (FMS)
PDF
Assistant Professor “Sapienza†University of Rome
Dean & Professor Department of Clinical Pharmacology
Specialist Orthopaedic Surgeon New Medical Centre
Specialist in Endocrinology and Diabetes
Journal of Rheumatology and Arthritis Research (JRAR) is a chronic autoimmune inflammatory disease that causes pain, stiffness, and swelling of the joints. It affects different parts of the body, mainly affects the joints, bones, and muscles etc. Journal of Rheumatology and Arthritis Research is a peer-reviewed journal publishes original research articles, and clinical studies on pediatric and adult rheumatologic and musculoskeletal conditions, including topics such as basic therapy, surgery, and imaging.
JRAR has international expert Editorial Board and Reviewer team follows the standard review process and makes editorial decisions based on the scientific merit. The journal encourages researchers to submit their original reports, editorials, and letters for publication.
TO determine if anti-cyclic citrullinated peptide antibody (anti-CCP) is associated With elevated cardiovascular risk in patients with rheumatoid arthritis (RA) and in patients without autoimmune disease.
Fantus SATo evaluate the prevalence of non-adherence to corticosteroid, disease.nuklifying antirheumatic drug (DMARD) and biologic treatments in patients managed for chronic inflammatory rheumatic disease (CIRD)
Raja ALAYAHaematological manifestations are frequently seen in systemic lupus erythematosus (SLE). Although mild cytopaenia is common in SLE, rarely are blood dyscrasias the presenting features of the disease.
O AdelowoUnfortunately, the currently avai-lable therapies of this puzzling disorder remains modest. To go any further, we must thetefore focus on its pathophysiopathology.
Goff PL